Benefits vs. side effects of Adalimumab treatment in Psoriasis/Psoriatic Arthritis

@inproceedings{Hannawi2017BenefitsVS,
  title={Benefits vs. side effects of Adalimumab treatment in Psoriasis/Psoriatic Arthritis},
  author={Suad Hannawi and United Arab Emirates Prevnetion and Issa Al Salmi},
  year={2017}
}
Psoriatic Arthritis (PsA) is a seronegative, inflammatory joint disease. In most patients with PSA, skin psoriasis precedes arthritis; however, the causality is multi-factorial and many aspects related to it remain unclear. Tumor necrosis factor (TNF) plays essential role in the pathogenesis of PsA and psoriasis. Hence, the selective inhibition of TNF-α leads to significant improvement of disease activity in patients with immunologically mediated inflammation such as psoriasis and PsA… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Problems encountered during anti-tumour necrosis factor therapy.

  • Best practice & research. Clinical rheumatology
  • 2006
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

AA Saad, DM Ashcroft, +4 authors Bsrbr
  • Rheumatology
  • 2010
VIEW 1 EXCERPT

Biologics in the management of psoriasis

  • Clinical, cosmetic and investigational dermatology
  • 2009
VIEW 1 EXCERPT

Adalimumab in dermatology.

  • British journal of clinical pharmacology
  • 2008
VIEW 1 EXCERPT